MEDICATION SHEETS

Student name: Allie Jones

Date: September 14th, 2009

Drug name: Rhogam

Drug Classification: immune globulins
Pregnancy Risk Category: C
Indication for use in this area: Rh- patient exposed to Rh+ blood by
pregnancy or delivery of an Rh+ infant or fetal-maternal hemorrhage
due to amniocentesis
Route and usual range of dose: IM; before delivery: 1 vial standard
dose (300 mcg) at 26-28 weeks, following delivery: 1 vial standard
dose (300 mcg) within 72 hours of delivery.
Specific dosing for your patient: 7324/7322: N/A
Potential side effects/adverse reactions/ nursing considerations:
injection site reactions including: swelling/redness/pain/warmth, skin
rash, body aches; explain to the patient the purpose of the medication
in protection of future Rh+ infants
Evaluation of Medication: prevention of erythroblastosis fetalis
(antibody response and hemolytic disease of the newborn)

Drug name: Motrin

Drug Classification: nonopioid analgesics, NSAID
Pregnancy Risk Category: B (1st trimester), otherwise C
Indication for use in this area: mild to moderate pain
Route and usual range of dose: PO 400 – 600 mg Q4-6hrs
Specific dosing for your patient: 7324: 400-600 mg Q4-6 hours PRN,
7322: 400 mg Q4 hrs PRN
Potential side effects/adverse reactions/ nursing considerations:
headache, dizziness, rhinitis/tinnitus; additive adverse GI side effects
with other NSAIDs and corticosteroids
Evaluation of Medication: decrease in severity of pain

Drug name: Percocet

Drug Classification: opioid agonists, opioid agonist/nonopioid
analgesic combinations
Pregnancy Risk Category: C (oxycodone alone)
Indication for use in this area: moderate to moderately severe pain
Route and usual range of dose: PO 5 – 10 mg q 3 – 4 hr oxycodone &
325 mg acetaminophen; acetaminophen or aspirin dosage should not
exceed 4 g/day
Specific dosing for your patient: 7324/7322: 5/325 1-2 tabs Q4 hours
PRN
Potential side effects/adverse reactions/ nursing considerations:
confusion, sedation, respiratory depression, constipation; use with
caution in patients receiving MAO inhibitors;
Evaluation of Medication: decrease in severity of pain without a
significant alteration in LOC/respiratory status.

Drug name: Toradol

Drug Classification: nonsteroidal anti-inflammatory agents, nonopioid
analgesics
Pregnancy Risk Category: C
Indication for use in this area: short-term management of pain (<5
days)
Route and usual range of dose: PO, 20 mg initially, followed by 10 mg
q 4 – 6 hr PRN; IV, single dosing 30 mg q 6 hr
Specific dosing for your patient: 7324: 30 mg IV Q4 x4 doses; 7322:
N/A
Potential side effects/adverse reactions/ nursing considerations:
drowsiness, dizziness, GI bleeding, anaphylaxis; patients with a history
of asthma/aspirin-induced allergy/nasal polyps have increased risk for
development of hypersensitivity reactions.
Evaluation of Medication: decrease in severity of pain, patients not
responding to one NSAID may respond to another.

Drug name: Colace

Drug Classification: stool softener
Pregnancy Risk Category: C
Indication for use in this area: prevention of constipation through
promoting incorporation of water into stool, resulting in softer fecal
mass.
Route and usual range of dose: PO, 50 – 400 mg in 1 – 4 divided doses
Specific dosing for your patient: 7324/7322: two 100 mg BID
Potential side effects/adverse reactions/ nursing considerations:
hypersensitivity; encourage other forms of bowel regulation (increased
bulk/fluid intake, increased mobility) as this medication does not
stimulate intestinal peristalsis; throat irritation, mild cramps, rashes.
Evaluation of Medication: Soft, formed bowel movement usually within
24 hours to five days.

Drug name: Ampicillin

Drug Classification: aminopenicillins
Pregnancy Risk Category: B
Indication for use in this area: prevention of infection in high-risk
patients undergoing cesarean section; treatment of moderate urinary
tract infection
Route and usual range of dose: PO, IV preferred 250mg - 500 mg QID
(IM available)
Specific dosing for your patient:7322/7324:N/A
Potential side effects/adverse reactions/ nursing considerations:
distributed into breast milk, can cause rash/diarrhea/sensitization in
the infant; diarrhea, rashes; rapid administration can cause seizures
Evaluation of Medication: prophylaxis prevention of infection,
treatment of urinary tract infections in the postpartum patient